| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/TP.0B013E3181AAD256 |
| P698 | PubMed publication ID | 19584693 |
| P50 | author | Kevin C. Abbott | Q43439652 |
| P2093 | author name string | Lawrence Y Agodoa | |
| Rahul M Jindal | |||
| Frank P Hurst | |||
| Robert T Neff | |||
| David Y Yoo | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Pneumocystis jirovecii | Q134478 |
| P304 | page(s) | 135-141 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia | |
| P478 | volume | 88 |
| Q46479577 | A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection |
| Q34133917 | A systematic review of validated methods for identifying infection related to blood products, tissue grafts, or organ transplants using administrative data |
| Q38688900 | Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection |
| Q45070975 | Clindamycin-primaquine for pneumocystis jiroveci pneumonia in renal transplant patients. |
| Q36185559 | Clinical Course, Radiological Manifestations, and Outcome of Pneumocystis jirovecii Pneumonia in HIV Patients and Renal Transplant Recipients |
| Q33999209 | Cost-effectiveness analysis of diagnostic options for pneumocystis pneumonia (PCP) |
| Q84356317 | Duration of prophylaxis with trimethoprim-sulfamethoxazole in patients undergoing solid organ transplantation |
| Q33896940 | Fungal infections in transplant and oncology patients |
| Q40235213 | High-dose calcineurin inhibitor-free everolimus as a maintenance regimen for heart transplantation may be a risk factor for Pneumocystis pneumonia. |
| Q47159286 | Hypercalcaemia preceding diagnosis of Pneumocystis jirovecii pneumonia in renal transplant recipients. |
| Q64891355 | Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome. |
| Q42262587 | Impaired thymic function and CD4+ T lymphopenia, but not mannose-binding lectin deficiency, are risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients |
| Q37822145 | Incidence and risk factors for pulmonary mycosis in kidney transplantation |
| Q42272268 | Interactions between anti-infective agents and immunosuppressants in solid organ transplantation |
| Q41810279 | Late presentation of Pneumocystis jiroveci pneumonia after cardiac transplantation |
| Q39265885 | Late-onset Pneumocystis jirovecii pneumonia in solid organ transplant recipients |
| Q36288984 | Management of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak |
| Q37305589 | Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jirovecii |
| Q35084980 | Pathological and protective immunity to Pneumocystis infection |
| Q48149271 | Pneumocystis Pneumonia in Solid-Organ Transplant Recipients |
| Q39012798 | Pneumocystis jirovecii colonization among renal transplant recipients |
| Q37957313 | Pneumocystis jirovecii pneumonia in kidney transplantation |
| Q42201539 | Pneumocystis jirovecii pneumonia in patients with end-stage renal disease: a comparison with the general population |
| Q42260686 | Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience |
| Q50992836 | Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis. |
| Q34461860 | Pneumocystis pneumonia induced by treatment with low-dose tacrolimus and methylprednisolone in a patient with rheumatoid arthritis: a case report |
| Q90242163 | Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab |
| Q58614726 | Prevalence and genotyping of Pneumocystis jirovecii in renal transplant recipients-preliminary report |
| Q46712383 | Probing Transplant and Living Donor Candidates about Their Participation in Organ Vending |
| Q40417600 | Risk Evaluation and Outcome of Pneumocystis jirovecii Pneumonia in Kidney Transplant Patients. |
| Q33685858 | Risk factors for Pneumocystis jirovecii pneumonia (PJP) in kidney transplantation recipients. |
| Q41605436 | Risk factors of Pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis |
| Q99416262 | Role of Serum (1,3)-Β-D-Glucan to Screen for Pneumocystis Pneumonia in Kidney Transplant Recipients |
| Q92786591 | Severe hypercalcemia preceding a diagnosis of Pneumocystis jirovecii pneumonia in a liver transplant recipient |
| Q93104990 | Transcriptomic and Proteomic Approaches to Finding Novel Diagnostic and Immunogenic Candidates in Pneumocystis |
| Q93074064 | WITHDRAWN: [Infectious complications after kidney transplantation] |
Search more.